A Streamline Strategy for Indication and Length of Telemetry Monitoring After TAVR
Catheterization and Cardiovascular Interventions · 2026
DOI: 10.1002/ccd.70299 ↗At a glance
Beobachtungsstudie in Catheterization and Cardiovascular Interventions, 2026. Written by Antonin Fournier and 13 co-authors. Institution: Department of Cardiology, CHU Montpellier, Montpellier, France. Major MEDLINE topics: Transcatheter Aortic Valve Replacement, Telemetry, Arrhythmias, Cardiac, Aortic Valve Stenosis. Cited 3 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Background
Both indication and length of ECG telemetry monitoring (TM) after transcatheter aortic valve replacement (TAVR) are not well defined.
Aims
We hypothesize that a targeted strategy for monitoring conductive disorders (CD) post‐TAVR can reduce the need and duration of in‐hospital TM without compromising safety.
Methods
We prospectively evaluated consecutive patients undergoing transfemoral TAVR between February 2023 and September 2024. Intensive care unit (ICU) transfer for TM was considered when previous right bundle branch block or when new or worsening CD. TM duration was standardized, from 24 to 48 h. The primary endpoint was incidence of severe CD, defined as symptomatic or requiring medical intervention, occurring outside the ICU, at 1‐month follow‐up.
Results
Among 250 patients included (mean age: 80.53 ± 6.86 years), 138 (55.20%) required TM, mainly due to new left bundle branch block ( n = 64, 44.80%). By respecting the protocol, the primary endpoint was achieved for three patients (1.20%, 95% CI: 0.31; 3.77), all related to post‐discharge CD occurring after Day 6 and requiring permanent pacemaker implantation (PPI). There were no deaths and no severe in‐hospital CD outside the ICU. The PPI rate was 16.80%. The mean ICU length of stay was 1.34 days. Absence of TM was associated with shorter mean global hospitalization duration (1.43 vs. 2.93 days, p < 0.001).
Conclusion
Selective indication and length of TM after TAVR is possible with no in‐hospital events, no deaths, and a low rate of rhythmic events after hospital discharge, confirming the safety of this in‐hospital strategy. Nearly half of the patients did not require TM, and very short global and ICU lengths were observed.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Cardiology, CHU Montpellier, Montpellier, France.
- Department of Cardiology, CHU Nîmes, Nîmes, France.
- Clinical Research and Epidemiology Unit, CHU Montpellier, Univ Montpellier, Montpellier, France.
- Department of Cardiac Surgery, CHU Montpellier, Montpellier, France.
ORCID profiles: Antonin Fournier, Benoit Lattuca, Jean-Christophe Macia, François Roubille, Florence Leclercq
Cite
APA
Fournier, A., Robert, P., Lattuca, B., Duflos, C., Duroyon, M. M., Macia, J. C., Schmutz, L., Steinecker, M., Berdeu, J. M., Gandet, T., Pasquie, J. L., Roubille, F., Cayla, G., & Leclercq, F. (2026). A Streamline Strategy for Indication and Length of Telemetry Monitoring After TAVR. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70299
Vancouver
Fournier A, Robert P, Lattuca B, Duflos C, Duroyon MM, Macia JC, et al. A Streamline Strategy for Indication and Length of Telemetry Monitoring After TAVR. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70299
BibTeX
@article{Fournier2026,
author = {Fournier, Antonin and Robert, Pierre and Lattuca, Benoit and Duflos, Claire and Duroyon, Maël-Morvan and Macia, Jean-Christophe and Schmutz, Laurent and Steinecker, Matthieu and Berdeu, Jean-Michel and Gandet, Thomas and Pasquie, Jean Luc and Roubille, François and Cayla, Guillaume and Leclercq, Florence},
title = {A Streamline Strategy for Indication and Length of Telemetry Monitoring After TAVR},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
doi = {10.1002/ccd.70299}
}
EUVIMED